A cost-effectiveness analysis of lisdexamfetamine dimesylate in the treatment of adults with attention-deficit/hyperactivity disorder in the UK
Evelina A. Zimovetz, Alain Joseph, Rajeev Ayyagari, Josephine A. Mauskopf
| Year of publication: |
January 2018
|
|---|---|
| Authors: | Zimovetz, Evelina A. ; Joseph, Alain ; Ayyagari, Rajeev ; Mauskopf, Josephine A. |
| Published in: |
The European journal of health economics : HEPAC ; health economics in prevention and care. - Berlin : Springer, ISSN 1618-7598, ZDB-ID 2045253-6. - Vol. 19.2018, 1, p. 21-35
|
| Subject: | ADHD | Lisdexamfetamine | Costeffectiveness analysis | Economic evaluation | Attentiondeficit/hyperactivity disorder | Adult | Kosten-Wirksamkeits-Analyse | Cost-effectiveness analysis | Psychische Krankheit | Mental disorder | Erwachsene | Adults | Gesundheitsökonomik | Health economics | Kosten-Nutzen-Analyse | Cost-benefit analysis |
| Type of publication: | Article |
|---|---|
| Type of publication (narrower categories): | Aufsatz in Zeitschrift ; Article in journal |
| Language: | English |
| Other identifiers: | 10.1007/s10198-016-0864-4 [DOI] |
| Source: | ECONIS - Online Catalogue of the ZBW |
Persistent link: https://www.econbiz.de/10011945849